The DOI matches its Crossref record; 428 of the 428 references it cites were found in a registry or an index.
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
Open accessAbstract
Diabetes mellitus type 2 is a world-wide growing health problem affecting more than 150 million people at the beginning of the new millennium. It is believed that this number will double in the next 25 yr. The pathophysiological hallmarks of type 2 diabetes mellitus consist of insulin resistance, pancreatic β-cell dysfunction, and increased endogenous glucose production. To reduce the marked increase of cardiovascular mortality of type 2 diabetic subjects, optimal treatment aims at normalization of body weight, glycemia, blood pressure, and lipidemia. This review focuses on the pathophysiology and molecular pathogenesis of insulin resistance and on the capability of antihyperglycemic pharmacological agents to treat insulin resistance, i.e., α-glucosidase inhibitors, biguanides, thiazolidinediones, sulfonylureas, and insulin. Finally, a rational treatment approach is proposed based on the dynamic pathophysiological abnormalities of this highly heterogeneous and progressive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 428
Mechanisms of the Glycaemic Effects of Sulfonylureas
Ashcroft, F. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979837 · Cited by 166
Mechanism of improvement in glucose metabolism after chronic glyburide therapy
Simonson, D. C., Ferrannini, E., Bevilacqua, S., Smith, D., Barrett, E., Carlson, R., & DeFronzo, R. A. (1984) · Diabetes · doi:10.2337/diabetes.33.9.838 · Cited by 166
Importance of the intestine as a site of metformin‐stimulated glucose utilization
Bailey, C. J., Mynett, K. J., & Page, T. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13128.x · Cited by 165
Zouali, H. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1401 · Cited by 165
Glimepiride: A Review of its Use in the Management of Type 2 Diabetes Mellitus
Langtry, H. D., & Balfour, J. A. (1998) · Drugs · doi:10.2165/00003495-199855040-00007 · Cited by 164
Some answers, more controversy, from UKPDS
Nathan, D. M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)22937-0 · Cited by 164
In vitro studies on the action of CS-045, a new antidiabetic agent
Ciaraldi, T. P., Gilmore, A., Olefsky, J. M., Goldberg, M., & Heidenreich, K. A. (1990) · Metabolism · doi:10.1016/0026-0495(90)90166-a · Cited by 164
Draeger, K., Wernicke-Panten, K., Lomp, H.-J., Schüler, E., & Roßkamp, R. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979830 · Cited by 161
New Susceptibility Locus for NIDDM Is Localized to Human Chromosome 20q
Ji, L., Malecki, M., Warram, J. H., Yang, Y., Rich, S. S., & Królewski, A. S. (1997) · Diabetes · doi:10.2337/diabetes.46.5.876 · Cited by 159
PPAR Tissue Distribution and Interactions with Other Hormone‐Signaling Pathwaysa
Lemberger, T., Braissant, O., Juge-Aubry, C. E., KELLER, H., Saladin, R., Staels, B., Auwerx, J. H., Burger, A., Meier, C. A., & Wahli, W. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18619.x · Cited by 156
The Gly972→Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic β cells
Porzio, O., Federici, M., Hribal, M. L., Lauro, D., Accili, D., Lauro, R., Borboni, P., & Sesti, G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5870 · Cited by 155
Fat metabolism in human obesity
Campbell, P. J., Carlson, M. G., & Nurjhan, N. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.4.e600 · Cited by 154
Johnson, A. B., Webster, J. M., Sum, C. F., Heseltine, L., Argyraki, M., Cooper, B. G., & Taylor, R. (1993) · Metabolism · doi:10.1016/0026-0495(93)90284-u · Cited by 154
Metabolic interactions between glucose and fatty acids in humans
Wolfe, R. R. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.3.519s · Cited by 152
Hoffmann, J., & Spengler, M. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00252-0 · Cited by 148
Sulfonylurea receptors and mechanism of sulfonylurea action
Panten, U., Schwanstecher, M., & Schwanstecher, C. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211414 · Cited by 147
Robinson, A. C., Burke, J., Robinson, S., Johnston, D. G., & Elkeles, R. S. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.701 · Cited by 146
Hoffmann, J., & Spengler, M. (1994) · Diabetes Care · doi:10.2337/diacare.17.6.561 · Cited by 143
Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione Troglitazone
Antonucci, T. K., Whitcomb, R. W., McLain, R. W., & Lockwood, D. H. (1997) · Diabetes Care · doi:10.2337/diacare.20.2.188 · Cited by 142
The pharmacology of sulfonylureas
Skillman, T. G., & Feldman, J. M. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90773-7 · Cited by 141
Best, J. D., Judzewitsch, R. G., Pfeifer, M. A., Beard, J. C., Halter, J. B., & Porte, D. (1982) · Diabetes · doi:10.2337/diab.31.4.333 · Cited by 140
Advantages of -Glucosidase Inhibition as Monotherapy in Elderly Type 2 Diabetic Patients
Johnston, P. S., Lebovitz, H. E., Coniff, R. F., Simonson, D. C., Raskin, P., & Munera, C. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4824 · Cited by 140
Horton, E. S., Whitehouse, F. W., Ghazzi, M. N., Venable, T. C., The Troglitazone Study Group, & Whitcomb, R. W. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1462 · Cited by 138
Coniff, R. F., Shapiro, J., Robbins, D. C., Kleinfield, R., Seaton, T. B., Beisswenger, P. J., & McGill, J. B. (1995) · Diabetes Care · doi:10.2337/diacare.18.6.817 · Cited by 135
Clinical Evaluation of Glimepiride versus Glyburide in NIDDM in a Double-Blind Comparative Study
Dills, D. G., & Schneider, J. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979831 · Cited by 134
Procházka, M., Lillioja, S., Tait, J. F., Knowler, W. C., Mott, D. M., Spraul, M., Bennett, P. H., & Bogardus, C. (1993) · Diabetes · doi:10.2337/diab.42.4.514 · Cited by 134
Müller, G. A., Satoh, Y., & Geisen, K. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01089-v · Cited by 130
Groop, L., Bonadonna, R. C., Simonson, D. C., Petrides, A. S., shank, M. L., & DeFronzo, R. A. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.1.e79 · Cited by 129
Fulgencio, J.-P., Kohl, C., Girard, J. R., & Pégorier, J. P. (1996) · Diabetes · doi:10.2337/diab.45.11.1556 · Cited by 129
Rosenstock, J., Samols, E., Muchmore, D. B., Schneider, J., & The Glimepiride Study Group (1996) · Diabetes Care · doi:10.2337/diacare.19.11.1194 · Cited by 128
Requirement of Protein Kinase Cζ for Stimulation of Protein Synthesis by Insulin
Méndez, R., Kollmorgen, G., White, M. F., & Rhoads, R. E. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5184 · Cited by 127
A Review of the Safety and Efficacy of Acarbose in Diabetes Mellitus
Yee, H. S., & Fong, N. T. (1996) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1996.tb02997.x · Cited by 123
Firth, R. G., Bell, P. M., & Rizza, R. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605153142003 · Cited by 122
Zimmerman, B. R. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70264-4 · Cited by 121
Maloff, B. L., & Lockwood, D. H. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110257 · Cited by 119
Tanizawa, Y., Okuya, S., Ishihara, H., Asano, T., Yada, T., & Oka, Y. (1997) · Endocrinology · doi:10.1210/endo.138.10.5576 · Cited by 118
Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes
Nielsen, O. H., Schmitz, O., Andersen, P. H., Beck‐Nielsen, H., & Pedersen, O. B. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200257 · Cited by 118
Continuous Subcutaneous Insulin Infusion Therapy Decreases Insulin Resistance in Type 1 Diabetes*
Yki‐Järvinen, H., & Koivisto, V. A. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-4-659 · Cited by 117
Greenfield, M. S., Doberne, L., Rosenthal, M. J., Schulz, B., Widström, A., & Reaven, G. M. (1982) · Diabetes · doi:10.2337/diab.31.4.307 · Cited by 117
Fujiwara, T., Wada, M., Fukuda, K., Fukami, M., Yoshioka, S., Yoshioka, T., & Horikoshi, H. (1991) · Metabolism · doi:10.1016/0026-0495(91)90218-l · Cited by 115
Segal, P., Feig, P., Schernthaner, G.-H., Ratzmann, K. P., Rybka, J., Petzinna, D., & Berlin, C. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.687 · Cited by 114
Koch, M., Kristian, R. E. T. T., Maerker, E., Volk, A., Haist, K., Deninger, M., Renn, W., & Häring, H. (1999) · Diabetologia · doi:10.1007/s001250051225 · Cited by 114
Matthaei, S., Hamann, A., Klein, H. H., Benecke, H., Kreymann, G., Flier, J. S., & Greten, H. (1991) · Diabetes · doi:10.2337/diab.40.7.850 · Cited by 113
Self-citationWang, M., Wise, S., Leff, T., & Su, T. Z. (1999) · Diabetes · doi:10.2337/diabetes.48.2.254 · Cited by 112
Widén, E., Eriksson, J. G., & Groop, L. (1992) · Diabetes · doi:10.2337/diab.41.3.354 · Cited by 110
Nosadini, R., Avogaro, A., Trevisan, R., Valerio, A., Tessari, P., Duner, E., Tiengo, A., Velussi, M., Prato, S. D., de Kreutzenberg, S., et al. (1987) · Diabetes Care · doi:10.2337/diacare.10.1.62 · Cited by 109
Leptin and OB-R: Body weight regulation by a cytokine receptor
White, D. W., & Tartaglia, L. A. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00040-8 · Cited by 108
Berkowitz, K. M., Peters, R., Kjos, S. L., Goico, J., Marroquin, A., Dunn, M. E., Xiang, A. H., Azen, S. P., & Buchanan, T. A. (1996) · Diabetes · doi:10.2337/diab.45.11.1572 · Cited by 108
Nolan, J. J. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.471 · Cited by 108
Obermaier-Kusser, B., White, M. F., Pongratz, D. E., Su, Z., Ermel, B., Mühlbacher, C., & Häring, H.-U. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60559-9 · Cited by 107
Maegawa, H., Shigeta, Y., Egawa, K., & Kobayashi, M. (1991) · Diabetes · doi:10.2337/diab.40.7.815 · Cited by 107
Oral antidiabetic combination therapy with sulphonylureas and metformin.
Haupt, E., Knick, B., Koschinsky, T., Liebermeister, H., Schneider, J., & Hirche, H. (1991) · PubMed · Cited by 107
Glyburide: A Second‐generation Sulfonylurea Hypoglycemic Agent
Feldman, J. M. (1985) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1985.tb03404.x · Cited by 105
Müller, G. A., & Wied, S. (1993) · Diabetes · doi:10.2337/diab.42.12.1852 · Cited by 105
Pénicaud, L., Hitier, Y., Ferré, P., & Girard, J. R. (1989) · Biochemical Journal · doi:10.1042/bj2620881 · Cited by 105
Rosenkranz, B., Profozić, V., Metelko, Ž., Mrzljak, V., Lange, C., & Malerczyk, V. (1996) · Diabetologia · doi:10.1007/s001250050624 · Cited by 102
Laakso, M., Uusitupa, M., Takala, J., Majander, H., Reijonen, T., & Penttilä, I. (1988) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(88)90074-1 · Cited by 101
Leptin activates ATP‐sensitive potassium channels in the rat insulin‐secreting cell line, CRI‐G1
Harvey, J., McKenna, F., Herson, P. S., Spanswick, D. C., & Ashford, M. L. J. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.527bd.x · Cited by 101
Characterization of the Molecular Mode of Action of the Sulfonylurea, Glimepiride, at β-Cells
Kramer, W., Müller, G. A., & Geisen, K. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979838 · Cited by 100
Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and mice
Fujiwara, T., Okuno, A., Yoshioka, S., & Horikoshi, H. (1995) · Metabolism · doi:10.1016/0026-0495(95)90056-x · Cited by 100
O’Rahilly, S., Choi, W. H., Patel, P., Turner, R. C., Flier, J. S., & Moller, D. E. (1991) · Diabetes · doi:10.2337/diab.40.6.777 · Cited by 100
Buckingham, R. E., Albarazanji, K. A., Toseland, C. D. N., Slaughter, M., Connor, S. C., West, A., Bond, B. J., Turner, N. C., & Clapham, J. C. (1998) · Diabetes · doi:10.2337/diabetes.47.8.1326 · Cited by 100
McIntyre, D. H., Paterson, C. A., Ma, A., Ravenscroft, P. J., Bird, D., & Cameron, D. P. (1991) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1991.tb01375.x · Cited by 98
Pharmacokinetics of Oral Antihyperglycaemic Agents in Patients with Renal Insufficiency
Harrower, A. D. B. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631020-00003 · Cited by 97
Goldberg, R. B., Holvey, S. M., Schneider, J., et al. (1996) · Diabetes Care · doi:10.2337/diacare.19.8.849 · Cited by 97
Acarbose: Its Role in the Treatment of Diabetes Mellitus
Campbell, L. K., White, J. R., & Campbell, R. K. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603001110 · Cited by 97
Zhang, Y., Wat, N. M. S., STRATTON, I. M., Warren-Perry, M., Orho, M., Groop, L., & Turner, R. C. (1996) · Diabetologia · doi:10.1007/s001250050605 · Cited by 96
Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans
Bijlstra, P. J., Lutterman, J. A., Rüssel, F. G. M., Thien, T., & Smits, P. (1996) · Diabetologia · doi:10.1007/bf00400658 · Cited by 96
Reaven, G. M., Johnston, P., Hollenbeck, C. B., Skowroński, R., Zhang, J. C., Goldfine, I. D., & Chen, Y. I. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.5.1569149 · Cited by 96
Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus.
Prager, R., Schernthaner, G.-H., & Graf, H. (1986) · PubMed · Cited by 96
Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes
Pagano, G., Tagliaferro, V., Carta, Q., Caselle, M. T., Bozzo, C., Vitelli, F., Trovati, M., & Cocuzza, E. (1983) · Diabetologia · doi:10.1007/bf00251823 · Cited by 94
Acarbose-induced acute severe hepatotoxicity
Carrascosa, M. F., Pascual, F., & Zárate, S. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)60134-1 · Cited by 93
Glimepiride: Role of a New Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus
Campbell, R. K. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17360 · Cited by 91
Metformin Revisited: Its Actions and Indications for Use
Bailey, C. J. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb00996.x · Cited by 90
Coniff, R. F., Shapiro, J. A., & Seaton, T. B. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420210080009 · Cited by 90
Effects of Leptin on Insulin Secretion From Isolated Rat Pancreatic Islets
Ookuma, M., Ookuma, K., & York, D. A. (1998) · Diabetes · doi:10.2337/diab.47.2.219 · Cited by 90
Pharmacokinetic-Pharmacodynamic Relationships of Acarbose
Salvatore, T., & Giugliano, D. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630020-00002 · Cited by 88
Cardiovascular Effects of Conventional Sulfonylureas and Glimepiride
Geisen, K., Végh, Á., Krause, E., & Papp, J. G. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979841 · Cited by 88
Mimura, K., Umeda, F., Hiramatsu, S., Taniguchi, S., Ono, Y., Nakashima, N., Kobayashi, K., Masakado, M., Yoshiyasu, S. A. K. O., & Nawata, H. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00333.x · Cited by 87
Matsumoto, K., Yano, M., Miyake, S., Ueki, Y., Yamaguchi, Y., Akazawa, S., & Tominaga, Y. (1998) · Diabetes Care · doi:10.2337/diacare.21.2.256 · Cited by 87
Troglitazone Prevents Glucose-Induced Insulin Resistance of Insulin Receptor in Rat-1 Fibroblasts
Kellerer, M., Kroder, G., Tippmer, S., Berti, L., Kiehn, R., Mosthaf, L., & Häring, H. U. (1994) · Diabetes · doi:10.2337/diab.43.3.447 · Cited by 87
Self-citationTroglitazone Use in Insulin-Treated Type 2 Diabetic Patients
Buse, J. B., Gumbiner, B., Mathias, N. P., Nelson, D. M., Faja, B. W., Whitcomb, R. W., & The Troglitazone Insulin Study Group (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1455 · Cited by 86
One year comparative trial of metformin and glipizide in type 2 diabetes mellitus.
Campbell, I. W., Menzies, D. G., Chalmers, J., McBain, A. M., & Brown, I. R. F. (1994) · PubMed · Cited by 85
Metformin and the sulphonylureas: the comparative risk.
Campbell, I. W. (1985) · PubMed · Cited by 85
Reaven, G. M., Lardinois, C. K., Greenfield, M. S., Schwartz, H. C., & Vreman, H. J. (1990) · Diabetes Care · doi:10.2337/diacare.13.3.32 · Cited by 84
Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene.
Harris, P. K. W., & Kletzien, R. F. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10015-1 · Cited by 84
Evidence of Increased Systemic Glucose Production and Gluconeogenesis in an Early Stage of NIDDM
Perriello, G., Pampanelli, S., Sindaco, P., Lalli, C., Ciofetta, M., Volpi, E., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1997) · Diabetes · doi:10.2337/diab.46.6.1010 · Cited by 83
Matthaei, S., Reibold, J. P., Hamann, A., Benecke, H., Häring, H.-U., Greten, H., & Klein, H. H. (1993) · Endocrinology · doi:10.1210/endo.133.1.8391425 · Cited by 83
Self-citationLager, I., Lönnroth, P., von Schenck, H., & Smith, U. (1983) · BMJ · doi:10.1136/bmj.287.6406.1661 · Cited by 83
Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin.
Riccio, A., Prato, S. D., de Kreutzenberg, S. V., & Tiengo, A. (1991) · PubMed · Cited by 83
Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients
Gin, H., Messerchmitt, C., Brottier, E., & Aubertin, J. (1985) · Metabolism · doi:10.1016/0026-0495(85)90139-8 · Cited by 82
Ratheiser, K. M., Schneeweiss, B., Waldhäusl, W., Fasching, P., Korn, A., Nowotny, P., Rohac, M., & Wolf, H. (1991) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(91)90214-h · Cited by 82
Thies, R. S., Molina, J. M., Ciaraldi, T. P., Freidenberg, G. R., & Olefsky, J. M. (1990) · Diabetes · doi:10.2337/diab.39.2.250 · Cited by 82
Iwamoto, Y., Kosáka, K., Kuzuya, T., Akanuma, Y., Shigeta, Y., & Kaneko, T. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199604)13:4<365::aid-dia19>3.0.co;2-m · Cited by 81
1 Cellular insulin action and insulin resistance
Garvey, W. T., & Birnbaum, M. J. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80237-x · Cited by 81
Bernal, D., Almind, K., Yenush, L., Ayoub, M., Zhang, Y., Rosshani, L., Larsson, C., Pedersen, O. B., & White, M. F. (1998) · Diabetes · doi:10.2337/diabetes.47.6.976 · Cited by 79
Masuda, K., Okamoto, Y., Tsuura, Y., Kato, S., Miura, T., Tsuda, K., Horikoshi, H., Ishida, H., & Seino, Y. (1995) · Diabetologia · doi:10.1007/bf02369349 · Cited by 77
Grant, P. J., Stickland, M. H., Booth, N. A., & Prentice, C. R. M. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01610.x · Cited by 77
Stern, M. P., Duggirala, R., Mitchell, B. D., Reinhart, L. J., Shivakumar, S., Shipman, P. A., Uresandi, O. C., Benavides, E., Blangero, J., & O'Connell, P. (1996) · Genome Research · doi:10.1101/gr.6.8.724 · Cited by 76
The Effect of Glibenclamide and Metformin on Serum Lipoproteins in Type 2 Diabetes
Rains, S. G. H., Wilson, G. A., Richmond, W., & Elkeles, R. S. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb01074.x · Cited by 76
Salhanick, A. I., Konowitz, P., & Amatruda, J. M. (1983) · Diabetes · doi:10.2337/diab.32.3.206 · Cited by 76
Ginsberg, H. N., & Rayfield, E. J. (1981) · Diabetes · doi:10.2337/diab.30.9.739 · Cited by 76
Bailey, C. J., & Nattrass, M. (1988) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(88)80043-0 · Cited by 73
Double-Blind Evaluation of Efficacy and Tolerability of Metformin in NIDDM
Dornan, T., Heller, S. R., Peck, G. M., & Tattersal, R. B. (1991) · Diabetes Care · doi:10.2337/diacare.14.4.342 · Cited by 73
Lalor, B., Bhatnagar, D., Winocour, P. H., Ishola, M., Arrol, S., Brading, M., & Durrington, P. N. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01378.x · Cited by 73
Bak, J. F., Møller, N., Schmitz, O., Saaek, A., & Pedersen, O. B. (1992) · Diabetologia · doi:10.1007/bf00429100 · Cited by 72
Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin
Abbasi, F., Carantoni, M., Chen, Y. D. I., & Reaven, G. M. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1301 · Cited by 72
Combining insulin and oral agents
Buse, J. B. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00339-9 · Cited by 71
Comparison of Tolbutamide and Metformin in Elderly Diabetic Patients
Josephkutty, S., & Potter, J. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01433.x · Cited by 71
Important Role of Insulin and Flow in Stimulating Glucose Uptake in Contracting Skeletal Muscle
Hespel, P., Vergauwen, L., Vandenberghe, K., & Richter, E. A. (1995) · Diabetes · doi:10.2337/diab.44.2.210 · Cited by 71
Kellerer, M., Kristian, R. E. T. T., Renn, W., Groop, L., & Häring, H. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979890 · Cited by 70
Self-citationHotta, N., Kakuta, H., Sano, T., Matsumae, H., Yamada, H., Kitazawa, S., & Sakamoto, N. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb00030.x · Cited by 70
Sulfonylureas Why, Which, and How?
Melander, A., Lebovitz, H. E., & FABER, O. K. (1990) · Diabetes Care · doi:10.2337/diacare.13.3.18 · Cited by 69
Sites of metformin-stimulated glucose metabolism
Wilcock, C., & Bailey, C. J. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90136-9 · Cited by 67
Hansen, T. F., Andersen, C., Echwald, S. M., Urhammer, S. A., Clausen, J. O., Vestergaard, H., Owens, D. R., Hansen, L., & Pedersen, O. B. (1997) · Diabetes · doi:10.2337/diab.46.3.494 · Cited by 65
Metabolic and Cardiovascular Responses to Epinephrine in Diabetic Autonomic Neuropathy
Hilsted, J., Richter, E. A., Madsbad, S., Tronier, B., Christensen, N. J., Hildebrandt, P. R., Damkjær, M., & Galbo, H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170705 · Cited by 65
O’Rahilly, S. (1998) · Nature · doi:10.1038/32769 · Cited by 64
Ahr, H. J., Boberg, M., Krause, H., Maul, W., Müller, F. O., Ploschke, H. J., Weber, H., & Wünsche, C. (1989) · PubMed · Cited by 62
Influence of oxidation polymorphism on phenformin kinetics and dynamics
Oates, N. S., Shah, R. R., Idle, J. R., & Smith, R. L. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.257 · Cited by 62
Puhakainen, I., & Yki‐Järvinen, H. (1993) · Diabetes · doi:10.2337/diab.42.12.1694 · Cited by 62
Biguanides and Sulfonylureas as Combination Therapy in NIDDM
Hermann, L. S. (1990) · Diabetes Care · doi:10.2337/diacare.13.3.37 · Cited by 61
Mandarino, L. J., & Gerich, J. E. (1984) · PubMed · Cited by 61
Shepherd, P. R., NAVÉ, B. T., Rincón, J., Nolte, L. A., Bevan, A. P., Siddle, K., Zierath, J. R., & Wallberg‐Henriksson, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.19000 · Cited by 61
Pancreatic and Extrapancreatic Sulfonylurea Receptors
Panten, U., Schwanstecher, M., & Schwanstecher, C. (1992) · Hormone and Metabolic Research · doi:10.1055/s-2007-1003387 · Cited by 59
Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Bd, P. (1984) · PubMed · Cited by 59
Selby, J. V., Ettinger, B. B., Swain, B. E., & Brown, J. B. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.38 · Cited by 58
Saloranta, C., Taskinen, M., Widén, E., Härkönen, M., Melander, A., & Groop, L. (1993) · Diabetes · doi:10.2337/diab.42.11.1559 · Cited by 58
Ward, G. M., Harrison, L. C., Proietto, J., Aitken, P. M., & Nankervis, A. J. (1985) · Diabetes · doi:10.2337/diab.34.3.241 · Cited by 58
Leptin inhibition of insulin secretion from isolated human islets
Fehmann, H. C., Berghöfer, P., Brandhorst, D., Brandhorst, H., Hering, B. J., Bretzel, R. G., & Göke, B. (1997) · Acta Diabetologica · doi:10.1007/s005920050083 · Cited by 58
NIDDM Associated With Mutation in Tyrosine Kinase Domain of Insulin Receptor Gene
Cocozza, S., Porcellini, A., Riccardi, G., Monticelli, A., Condorelli, G., Ferrara, A. M., Pianese, L., Miele, C., Capaldo, B., Bèguinot, F., et al. (1992) · Diabetes · doi:10.2337/diab.41.4.521 · Cited by 58
Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics
Gin, H., Freyburger, G., Boisseau, M., & Aubertin, J. (1989) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(89)90058-2 · Cited by 55
Bowen, L., Stein, P. P., Stevenson, R. W., & Shulman, G. I. (1991) · Metabolism · doi:10.1016/0026-0495(91)90124-f · Cited by 55
Pentikäinen, P. J., Voutilainen, E., Aro, A., et al. (1990) · Annals of Medicine · doi:10.3109/07853899009147912 · Cited by 55
Is muscle the major site of insulin resistance in Type 2 (non-insulin-dependent) diabetes mellitus?
Gerich, J. E. (1991) · Diabetologia · doi:10.1007/bf00400282 · Cited by 55
Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans
Nyomba, B. L. G., Ossowski, V., Bogardus, C., & Mott, D. M. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.6.e964 · Cited by 55
Collier, A., WATSON, H. H. K., Patrick, A. W., Ludlam, C. A., & Clarke, B. F. (1989) · PubMed · Cited by 55
Acute effects of troglitazone on in vivo insulin action in normal rats
Lee, M.-K., & Olefsky, J. M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90010-1 · Cited by 54
Direct Effects of Sulfonylurea Agents on Glucose Transport in the BC3H-1 Myocyte
Rogers, B. J., Standaert, M. L., & POLLET, R. J. (1987) · Diabetes · doi:10.2337/diab.36.11.1292 · Cited by 53
Sulfonylurea potentiates insulin-induced recruitment of glucose transport carrier in rat adipocytes.
Jacobs, D. B., & Jung, C. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89397-8 · Cited by 52
Hepatic Injury Caused by Acarbose
Andrade, R. J., Lucena, M. I., & Rodriguez-Mendizabal, M. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-10-199605150-00030 · Cited by 52
Clinical profile of the novel sulphonylurea glimepiride
Roβkamp, R., Wernicke‐Panten, K., & Draeger, E. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01228-4 · Cited by 52
Rosiglitazone and Hepatic Failure
Freid, J., Everitt, D. E., & Boscia, J. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00015 · Cited by 52
Multiple sites of insulin resistance: muscle, liver and adipose tissue
Stümvoll, M., & Jacob, S. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212083 · Cited by 52
Thompson, D. B., Janssen, R. C., Ossowski, V., Procházka, M., Knowler, W. C., & Bogardus, C. (1995) · Diabetes · doi:10.2337/diab.44.4.478 · Cited by 51
SCHNEIDER, J., Erren, T. C., Zöfel, P., & Kaffarnik, H. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90148-c · Cited by 51
Klein, H. H., Vestergaard, H., Kotzke, G., & Pedersen, O. (1995) · Diabetes · doi:10.2337/diab.44.11.1310 · Cited by 50
Shinozaki, K., Suzuki, M., Ikebuchi, M., Hirose, J., Harano, Y., & Harano, Y. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90139-0 · Cited by 50
Lebovitz, H. E. (1985) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1985.tb03405.x · Cited by 50
Kihara, Y., Ogami, Y., Tabaru, A., Unoki, H., & Otsuki, M. (1997) · Journal of Gastroenterology · doi:10.1007/bf02936954 · Cited by 49
Yki-Järvinen, H., Esko, N., Helve, E., & Taskinen, M. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90412-3 · Cited by 49
Molecular mechanisms of action of glyburide on the beta cell
BOYD, A. E., Aguilar‐Bryan, L., & Nelson, D. A. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90330-g · Cited by 49
Impairment of glucose disposal by infusion of triglycerides in humans: role of glycemia
Felley, C. P., Felley, E. M., van Melle, G. D., Frascarolo, P., Jéquier, E., & Felber, J. P. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.6.e747 · Cited by 49
Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients.
Pagano, G., Marena, S., Mansin, L. C., Cravero, F., Giorda, C. B., Bozza, M. J., & Rossi, C. M. (1995) · PubMed · Cited by 48
Control of hepatic gluconeogenesis: Role of fatty acid oxidation
González‐Manchón, C., Ayuso, M. S., & Parrilla, R. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90249-x · Cited by 48
Tominaga, M., Igarashi, M., Daimon, M., Eguchi, H., Matsumoto, M., Sekikawa, A. M., Yamatani, K., & Sasaki, H. (1993) · Endocrine Journal · doi:10.1507/endocrj.40.343 · Cited by 48
Bähr, M., von Holtey, M., Müller, G. A., et al. (1995) · Endocrinology · doi:10.1210/endo.136.6.7750476 · Cited by 48
Chronic Treatment of African-American Type 2 Diabetic Patients With β-Glucosidase Inhibition
Johnston, P. S., Feig, P. U., Coniff, R. F., Krol, A., Kelley, D. E., & Mooradian, A. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.416 · Cited by 47
Acarbose-Induced Acute Hepatitis
Díaz-Gutiérrez, F., Ladero, J. M., & Díaz‐Rubio, M. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.481_1.x · Cited by 47
Troglitazone increases the resistance of low density lipoprotein to oxidation in healthy volunteers
Cominacini, L., Young, M. M. R., Capriati, A., Garbin, U., Pasini, A., Campagnola, M., Davoli, A., Rigoni, A. M., Contessi, G. B., & Cascio, V. L. (1997) · Diabetologia · doi:10.1007/s001250050809 · Cited by 46
Volk, A., Renn, W., Overkamp, D., Mehnert, B., Maerker, E., Jacob, S., Balletshofer, B. M., Häring, H., & Kristian, R. E. T. T. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212089 · Cited by 46
Low-Dose Acarbose Improves Glycemic Control in NIDDM Patients Without Changes in Insulin Sensitivity
Jenney, A. W. J., Proietto, J., O’Dea, K., Nankervis, A. J., Traianedes, K., & D'Embden, H. (1993) · Diabetes Care · doi:10.2337/diacare.16.2.499 · Cited by 45
Wang, P., Kaneko, T., Wang, Y., & Sato, A. (1999) · Hepatology · doi:10.1002/hep.510290109 · Cited by 44
PPARγ and colorectal carcinoma: Conflicts in a nuclear family
Seed, B. (1998) · Nature Medicine · doi:10.1038/1990 · Cited by 44
Massi‐Benedetti, M., Herz, M., & Pfeiffer, C. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979836 · Cited by 44
The molecular interaction of sulfonylureas with β-cell ATP-sensitive K+-channels
Kramer, W., Müller, G. A., Girbig, F., Gutjahr, U., Kowalewski, S., Hartz, D., & Summ, H.-D. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01076-p · Cited by 44
Oral vanadate decreases muscle insulin resistance in obese fa/fa rats
Brichard, S., Ongemba, L. N., & Henquin, J. C. (1992) · Diabetologia · doi:10.1007/bf00400479 · Cited by 43
Influence of metformin on metabolic effect of insulin in human adipose tissue in vitro.
CIGOLINI, M., Bosello, O., Zancanaro, C., Orlandi, P. G., Fezzi, O., & Smith, U. (1984) · PubMed · Cited by 43
Halberstam, M., Cohen, N. D., Shlimovich, Rossetti, L., & Shamoon, H. (1996) · Diabetes · Cited by 43
Insulin signal transduction: possible mechanisms for insulin resistance*
Kellerer, M., Lammers, R., & Häring, H.-U. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212082 · Cited by 42
Self-citationBaier, L. J., Wiedrich, C., Hanson, R. L., & Bogardus, C. (1998) · Diabetes · doi:10.2337/diabetes.47.6.973 · Cited by 41
Leptin Stimulates Insulin Secretion and Synthesis in HIT-T 15 Cells
Shimizu, H., Ohtani, K.-I., Tsuchiya, T., Takahashi, H., Uehara, Y., Sato, N., & Mori, M. (1997) · Peptides · doi:10.1016/s0196-9781(97)00137-x · Cited by 41
Combined Therapy With a Sulfonylurea Plus Evening Insulin: Safe, Reliable, and Becoming Routine
Riddle, M. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979832 · Cited by 40
Lactate Turnover and Gluconeogenesis in Obesity: Effect of Phenformin
Kreisberg, R. A., Pennington, L. F., & Boshell, B. R. (1970) · Diabetes · doi:10.2337/diab.19.1.64 · Cited by 40
Noury, J., & Nandeuil, A. (1991) · PubMed · Cited by 39
D, M. P. S. M., Mitchell, B. D., Blangero, J., Reinhart, L. J., Krammerer, C. M., Harrison, C. R., Shipman, P. A., O'Connell, P., Frazier, M. L., & MacCluer, J. W. (1996) · Diabetes · doi:10.2337/diab.45.5.563 · Cited by 39
Hübinger, A., Knode, O., Susanto, F., Reinauer, H., & Gries, F. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979072 · Cited by 38
Landin‐Wilhelmsen, K., Tengborn, L., & Smith, U. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642523 · Cited by 38
Laube, H., Linn, T., & Heyen, P. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211981 · Cited by 38
Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients
Johnston, P. S., Feig, P. U., Coniff, R. F., Krol, A., Davidson, J. A., & Haffner, S. M. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.409 · Cited by 37
Ferner, R. E., Rawlins, M. D., & ALBERTT, K. G. M. M. (1988) · QJM · doi:10.1093/oxfordjournals.qjmed.a068185 · Cited by 37
Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes.
Marena, S., Tagliaferro, V., Montegrosso, G., Pagano, A., Scaglione, L., & Pagano, G. (1994) · PubMed · Cited by 37
Interactions Between Glucose and FFA Metabolism in Man
Saloranta, C., & Groop, L. (1996) · Diabetes/Metabolism Reviews · Cited by 37
Bektas, A., Warram, J. H., White, M. F., Krolewski, A. S., & Doria, A. (1999) · Diabetes · doi:10.2337/diabetes.48.3.640 · Cited by 36
Kolterman, O., PRINCE, M. J., & Olefsky, J. M. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90655-1 · Cited by 36
Gin, H., Slama, G., Weissbrodt, P., Poynard, T., Vexiau, P., Klein, J. C., & Tchobroutsky, G. (1982) · Diabetologia · doi:10.1007/bf00257727 · Cited by 36
Effects of glyburide on carbohydrate metabolism and insulin action in the liver
Caro, J. F. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90332-8 · Cited by 36
Clark, H., & Dr, M. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979835 · Cited by 35
Sulfonylureas in the Treatment of Diabetes Mellitus—1985
Gerich, J. E. (1985) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60866-0 · Cited by 35
Olefsky, J. M. (1993) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2910-1_10 · Cited by 34
Karunakara, S., Hammersley, M. S., Morris, R. J., Turner, R. C., & Holman, R. R. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90319-x · Cited by 33
Acarbose-induced generalised erythema multiforme
Kono, T., Hayami, M., Kobayashi, H., Ishii, M., & Taniguchi, S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02135-2 · Cited by 31
Metformin and metoprolol CR treatment in non‐obese men
Landin‐Wilhelmsen, K., Tengborn, L., & Smith, U. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01083.x · Cited by 31
Mertes, G. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00045-x · Cited by 30
Johnson, A. B., & Taylor, R. (1996) · Diabetes Care · doi:10.2337/diacare.19.6.559 · Cited by 29
Hart, L. M. ‘., Stolk, R. P., Heine, R. J., Grobbee, D. E., Does, F. E. E. V. D., & Maassen, J. A. (1996) · PubMed Central · Cited by 27
Modification of Lipoproteins in Diabetes
Lopes-Virella, M. F., Klein, R. L., & Virella, G. (1996) · Diabetes/Metabolism Reviews · doi:10.1002/(sici)1099-0895(199603)12:1<15::aid-dmr153>3.0.co;2-0 · Cited by 27
Scheen, A. J., Letiexhe, M. R., & Lefèbvre, P. J. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00410.x · Cited by 27
Pernet, A., Trimble, E. R., Kuntschen, F., Assal, J. ‐., Hahn, C., & Renold, A. E. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-2-247 · Cited by 27
Groop, L., & Widén, E. (1991) · PubMed · Cited by 27
Heart disease in diabetes mellitus: A challenge for early diagnosis and intervention
Tschoepe, D., & Roesen, P. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211944 · Cited by 26
Cited by
Association between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Transcriptional Regulation of Metabolism
Desvergne, B., Michalik, L., & Wahli, W. (2006) · Physiological Reviews · doi:10.1152/physrev.00025.2005 · Cited by 892
Er, L.-K., Wu, S., Chou, H.-H., Hsu, L.-A., Teng, M.-S., Sun, Y.-C., & Ko, Y.-L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149731 · Cited by 708
Metadata
- Authors
- Matthaei, S., Stumvoll, M., Kellerer, M., & Häring, H.-U.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2000-12-01
- Volume
- 21
- Issue
- 6
- Pages
- 585-618
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2011419421
- Cited by
- 377
- References
- 428
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.